A detailed history of Cerity Partners LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 42,917 shares of PACB stock, worth $83,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,917
Previous 53,043 19.09%
Holding current value
$83,688
Previous $72,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.2 - $2.17 $12,151 - $21,973
-10,126 Reduced 19.09%
42,917 $72,000
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $29,658 - $79,599
21,808 Added 69.82%
53,043 $72,000
Q1 2024

May 14, 2024

BUY
$3.52 - $9.59 $109,947 - $299,543
31,235 New
31,235 $117,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.